BNT327-01: Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy (clinicaltrials.gov) - Sep 15, 2026 - P2 | N=110 | Active, not recruiting | Sponsor: BioNTech SE | Trial completion date: May 2028 ➔ Feb 2028
Trial completion date • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
|